“This hopefully can give providers the ability to identify patients with resectable pancreatic cancer who may benefit ... would actually benefit from neoadjuvant therapy or chemoradiation ...

Opens in a new tab or window CHICAGO -- Neoadjuvant chemotherapy ... Surgery plus effective systemic therapy achieves the best outcomes in resectable pancreatic cancer, Labori noted.

“Previously, we needed to wait until after complex surgery to tell how the pancreatic cancer responded to the neoadjuvant therapy,” Abdelrahman said in a press release. “With FDG-PET we can ...

SAN DIEGO -- A preoperative combination of chemotherapy and immunotherapy (IO) appeared safe and effective for borderline resectable pancreatic cancer ... was to use neoadjuvant therapy to reduce ...

Novocure has several additional ongoing or completed clinical trials exploring the use of Tumor Treating Fields therapy in the treatment of glioblastoma, non-small cell lung cancer and pancreatic ...

Novocure to Present Results from the Phase 3 PANOVA-3 Clinical Trial of its Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer as a Late-Breaking Oral Presentation at the 2025 ASCO ...

Pain is a hallmark of this disease, and as a clinician, the potential of this therapy to address this aspect of pancreatic cancer is very encouraging. These results illustrate the potential of ...